Research & Development
FDA clears Hologic's assay for human cytomegalovirus
It is Hologic's first test to be available in the U.S. for identifying post-transplant pathogens using the company's automated Panther system. Aptima CMV Quant also has the CE Mark for diagnostic use and viral load testing in Europe, Hologic said.
May 11, 2022
CRISPR urine test helps assess kidney transplant patients
The research shows that CRISPR's promise in medical applications may be broader than initially thought, study lead author Dr. Michael Kaminski of the Max Delbrück Center for Molecular Medicine (MDC) and Charité - Universitätsmedizin, both in Berlin, said in a statement released jointly by the center and the university.
April 13, 2020
Roche launches adenovirus PCR test in Europe
Transplant patients are immunocompromised and at risk for developing infections, including from adenoviruses. Adenoviruses can lead to a range of conditions -- such as conjunctivitis, gastroenteritis, hepatitis, and pneumonia -- that cause complications and organ rejection in transplant patients.
January 14, 2020
Arc Bio showcases Galileo pathogen detection platform
GPS-Transplant is the first product to become available in Arc Bio's Galileo pathogen solutions line, with the company unveiling the assay at the American Society for Microbiology (ASM) Clinical Virology Symposium in Savannah, GA.
April 30, 2019
DNA forensic evidence frees Ohio man of rape, attempted rape
Chembio Diagnostics applies for FDA CLIA waiver for HIV, syphilis test
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Week in Review: Elizabeth Holmes sentenced; good cholesterol worse for some adults; earlier type 2 diabetes diagnosis; and more
Page 1 of 1